Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...

Lord John Mann, the government's independent advisor on antisemitism, who led the review with ex-Conservative cabinet ...

My Expert Midwife, a maternal health brand founded by practicing midwives, has secured £1.6m in follow-on funding to support ...

A British couple who renovated their dream home in France and now live mortgage-free say they would never move back to the UK thanks to the French lifestyle, the lower cost of living, and the ...

Hundreds of children and adults in England with rare forms of cystic fibrosis will now be able to access a new triple-combinatio ...

Dr Myrtle Emmanuel, Associate Professor in Human Resource Management & Organisational Behaviour at the University of ...

Parents in Milton Keynes have been alerted to the risk of measles, following reports this weekend that a child has sadly died of the disease in England.

The National Institute for Health and Care Excellence (Nice) has approved Alyftrek, a new modulator therapy for cystic fibrosis, hailed as "life-changing" by health experts.